American Society of Clinical Oncology (ASCO)-56th Annual Meeting

被引:0
|
作者
De Las Heras Prat, P. [1 ]
Diaz Santamaria, N. [1 ]
Rivera Libano, I. [1 ]
机构
[1] Clarivate, Barcelona, Spain
关键词
CX-2029; RGX-202; MK-6482; CC-92480; OH-2; MRG-003; 225Ac-J591; Alflutinib; Carfilzomib; Bortezomib; Zimberelimab; GC-1118; Osimertinib;
D O I
10.1358/dof.2020.45.8.3186999
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
On April 13, 2020, the American Society of Clinical Oncology (ASCO) announced that due to COVID-19, the annual meeting, held every spring in Chicago, would be cancelled. Instead, the organization announced a new and unprecedented replacement for the meeting in an online format. The ASCO20 Virtual Scientific Program was held on May 29-31, 2020. The ASCO20 theme was 'Unite & Conquer: Accelerating Progress Together,' an appropriate encouragement for scientific research at a time when it is most needed. The virtual online program included oral, poster and poster discussion presentations, as well as track-based Clinical Science Symposia throughout the weekend. In addition, the organizers announced that recordings of all broadcast sessions would be posted on the ASCO20 virtual platform for access regardless of time zone.
引用
收藏
页码:583 / 590
页数:8
相关论文
共 50 条
  • [21] American Society of Clinical Oncology-54th Annual Meeting
    Kibble, A.
    Al-Shamahi, A.
    Kuenneman, K.
    DRUGS OF THE FUTURE, 2018, 43 (08) : 617 - 626
  • [22] American Society of Clinical Oncology-55th Annual Meeting
    de las Heras Prat, P.
    Kunnemann, K.
    Kibble, A.
    DRUGS OF THE FUTURE, 2019, 44 (07) : 581 - 591
  • [23] American Society of Clinical Oncology 57th Annual Meeting
    Crossdell, G.
    Diaz Santamaria, N.
    Polychrones, J.
    DRUGS OF THE FUTURE, 2021, 46 (09) : 755 - 764
  • [24] THE ECSJ 56TH ANNUAL-MEETING
    TAKAHASHII, M
    DENKI KAGAKU, 1989, 57 (02): : 107 - 107
  • [25] Review of the oncological urology proceedings of the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
    Kirichek, A. A.
    Kamolov, B. Sh.
    Matveev, V. B.
    Nazranov, B. M.
    ONKOUROLOGIYA, 2018, 14 (03): : 143 - 148
  • [26] SELECTED ABSTRACTS FROM AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING 2012 Abstracts
    不详
    JOURNAL OF BREAST HEALTH, 2012, 8 (03): : 155 - 159
  • [27] 56TH ANNUAL CLINICAL CONGRESS OF AMERICAN COLLEGE OF SURGEONS
    NISSAN, S
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1971, 7 (05): : 710 - &
  • [28] Annual Meeting of the American Society of Clinical Oncology
    Cremolini, Chiara
    Loupakis, Fotios
    Falcone, Alfredo
    COLORECTAL CANCER, 2013, 2 (05) : 401 - 404
  • [29] Outcome of phase II oncology clinical trial abstracts presented at annual meeting of the American Society of Clinical Oncology (ASCO).
    Hoeg, R. T.
    Lee, J. A.
    Mathiason, M. A.
    Rokkones, K.
    Serck, S. L.
    Crampton, K. L.
    Emmel, A.
    Jumonville, A. J.
    Severson, E. A.
    Go, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 303S - 303S
  • [30] 2022 American Society of Clinical Oncology (ASCO): Meeting highlights
    Black, Peter C.
    Fallah-Rad, Nazanin
    Loblaw, Andrew
    Kassouf, Elie
    Keyes, Mira
    Basappa, Naveen S.
    Swaminath, Anand
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2022, 16 (09): : E499 - E504